Top Analyst Upgrades and Downgrades: American Airlines, ADM, BB&T, Cimarex, CRISPR, Editas, Grubhub, Kroger, NXP, Twitter, Walmart and More

Print Email

Stocks saw profit taking on Thursday, and that appeared to be the trend on Friday as well. Despite selling pressure, investors should consider that the Dow Jones industrials have risen by over 2,500 points above the lows from the start of January up to this week’s highs. Investors should be considering how they want their assets positioned for 2019 and beyond.

24/7 Wall St. reviews dozens of analyst research reports each day of the week, Our goal is to find new ideas for investors and traders alike. Some of these analyst reports cover stocks to buy, while others cover stocks to sell or to avoid.

Additional commentary has been added on most of the daily analyst reports, along with trading history. The consensus analyst price targets and other valuation metrics are from the Thomson Reuters sell-side research service.

These were the top analyst upgrades, downgrades and initiations seen on Friday, February 8, 2019.

American Airlines Group Inc. (NASDAQ: AAL) was started with a Hold rating at Argus. Its shares closed down 1.6% at $36.17 on Thursday and were indicated down 0.4% at $36.00 on Friday. Shares have a 52-week range of $28.81 to $57.44 and a consensus price target of $45.29.

Archer Daniels Midland Co. (NYSE: ADM) was raised to Buy from Hold at Stifel. ADM shares closed down 1.1% at $41.40 on Thursday and were indicated up 0.8% at $41.70 on Friday. The consensus target price is $53.40.

AutoZone Inc. (NYSE: AZO) was downgraded to Perform from Outperform at Oppenheimer. Shares most recently closed at $878.77, in a 52-week range of $590.76 to $896.03. The stock has a consensus price target of $919.00.

BB&T Corp. (NYSE: BBT) closed up almost 4% at $50.46 on Thursday on word it was merging with SunTrust. Merrill Lynch raised BB&T to Buy from Neutral.

Carbonite Inc. (NASDAQ: CARB) was down 15% at $24.75 in early indications on Friday after earnings and announcing it was acquiring Webroot. Stifel downgraded it to Hold from Buy and slashed the target price to $25 from $44. Shares have a 52-week range of $20.50 to $43.63 and a consensus price target of $40.64.

Century Communities Inc. (NYSE: CCS) was downgraded to Neutral from Outperform and the price target was lowered to $24 from $26 at Wedbush Securities. Shares closed at $23.90, in a 52-week range of $16.35 to $35.50. The consensus price target is $33.00.

Cimarex Energy Co. (NYSE: XEC) was raised to Positive from Neutral and the target price was raised to $88 from $74 (versus a $71.56 prior close) at Susquehanna.

CRISPR Therapeutics A.G. (NASDAQ: CRSP) was started with a Buy rating and assigned a $43 target price (versus a $29.78 close, after an 8.7% drop) at BTIG.

Editas Medicine Inc. (NASDAQ: EDIT) was started with a Buy rating and assigned a $30 price target (versus a $19.43 close, after a 7.9% drop) at BTIG.